Portfolio company
Juvena Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MyoPax
This company develops muscle regeneration cell and gene therapies for patients with congenital malformations, trauma, hereditary dystrophies and muscle wasting disorders.
Rejuveron Life Sciences
This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Dogma Biotech
This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.
Immunis
This biotechnology company develops stem cell-derived secretome therapies to treat age-related immune dysfunction and muscle wasting for patients with sarcopenia and metabolic diseases.
Cellergy Therapeutics
This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.
Immunis Biomedical
Immunis develops stem cell-derived secretome therapeutics to treat age-related muscle atrophy and metabolic dysfunction for patients with sarcopenia and obesity.
Fable Therapeutics
The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.
